Skip to content
Tirzepatide Report
Provider review

Rivo Health Tirzepatide Review: Annual Price and Terms

Published by Tirzepatide ReportUpdated

On this page

Annual-plan tirzepatide headline; full charge and governing terms need confirmation.

Standout details

  • Public panel identifies tirzepatide and displays an annual-plan price qualifier

Things to consider

  • No confirmed standalone month-to-month quote or full annual invoice
  • Linked treatment terms could not be verified; renewal and refund rules remain unconfirmed

Rivo Health’s current tirzepatide panel still displays $199/month with an annual-plan qualifier. It does not establish a separately purchasable month-to-month plan or the amount collected upfront. The linked treatment Terms could not be read through normal HTTPS on October 29, so cancellation and renewal rights remain unresolved.5,6

Read the annual qualifier with the price

The same panel includes a $389/month comparison amount and promotional savings language. It does not establish that every patient can buy one month for $199, that a particular amount will recur indefinitely or that every dose has the same price. Do not substitute either displayed figure for the actual order total.3

Published headline • What remains unconfirmed

Item to confirmCurrent evidence
Tirzepatide headline$199/month; annual-plan qualifier
Full annual charge and supplied periodNot verified; obtain accepted quote
Standalone monthly optionNot established by the reviewed panel
Renewal and refundsCurrent governing terms unconfirmed
The current panel carries an annual-plan condition; no selected full annual invoice or governing refund agreement was verified.5,6

The site advertises injectable and oral tirzepatide options. A shared ingredient or price panel does not establish equivalent formulations, quantities, effectiveness or dosing. Confirm the specific product, prescribed amount and supplied period rather than transferring an injection price or trial result to an oral preparation.1,2,3

Get the agreement before committing

The current cost FAQ says the selected price depends on treatment, plan, medication and provider review. Its nonqualification FAQ says a clinician may decline a prescription and suggest in-person care or another treatment. It does not promise a refund in that answer. Confirm what happens to any payment collected before that decision.5

The program's linked treatment terms could not be verified during this check. The cancellation deadline, automatic-renewal setting and unused-plan refund rules remain unconfirmed. Ask for the actual agreement, full amount due now, later charges and what happens if the clinician declines treatment or changes the prescription. A promotional monthly label does not answer those questions.3,4

Our earlier listing described a six-month promotional commitment; the current reviewed panel instead carries an annual-plan qualifier. We are not treating that older description as the current contract. Nor have we established a guaranteed regular price, refund right or cancel-anytime arrangement.

Confirm what the support bundle includes

Rivo's homepage advertises nutrition support, workouts, groups and coaching, while describing meal preparation as an optional add-on. These are program claims, not independently verified appointments or service levels. Confirm the professional providing each service, appointment availability, extra charges and whether support continues for the whole purchased period.3

Our Medsol RX review provides another care-support comparison. Compare the actual included appointments and contract rather than assuming that similar coaching language means the same service.

The platform and clinical decision are separate

An accessible telehealth consent dated May 30, 2026 describes remote care, its limitations and potential referral to in-person care. It says patients remain responsible for applicable service charges. This is a care-consent document, not the missing renewal or refund agreement; retrieving it now does not make it a newly revised contract.7

The current footer identifies Rivo Health, Inc. as the platform operator and attributes clinician review and prescribing decisions to Rimo Health. Those are the website’s stated identities, not independent verification of a corporate relationship, clinician credentials or assigned dispensing pharmacy. The public assessment is described as screening, with a clinician meeting after checkout to determine whether a prescription is appropriate.5

The website explains that its success-rate figure reflects internal fulfillment and delivery performance, not clinical outcomes. Testimonials, promotional comparisons and a separate ED nonqualification promise do not establish a tirzepatide refund guarantee. Obtain the named product’s accepted clinical and financial agreement before paying.5,6

Separate drug evidence from provider promises

The homepage describes compounded medications and says Rivo does not manufacture them. That does not identify the pharmacy assigned to a particular prescription or verify its credentials. We did not independently establish an assigned dispenser, current state eligibility or a personalized quote.3

Compounded tirzepatide is not an FDA-approved finished drug. SURMOUNT-1 and SURMOUNT-5 studied specified drugs and protocols, not this provider or its oral and compounded preparations.1,2 See our tirzepatide evidence guide and compounding legal-status guide. Discuss Zepbound side effects, gallbladder risk and the thyroid warning with the prescriber.

The practical next step is to obtain a written product quote and readable contract. For another published program's terms, see our RedBox Rx review and provider comparison; compare the same medication type, supplied period and payment commitment.

Frequently asked questions

Is Rivo Health tirzepatide $199 month to month?

The reviewed headline carries an annual-plan qualifier. We did not confirm a separately purchasable month-to-month option or the full accepted charge.

Are Rivo Health cancellation and refund terms confirmed?

No. The linked governing treatment terms could not be verified in this check. Obtain the actual agreement and cancellation deadline before paying.

Does the advertised bundle guarantee dietitian appointments?

The homepage advertises support services, but actual professional access, appointment availability and included services need confirmation for the selected plan.

Does Rivo’s current nonqualification FAQ promise a refund?

No refund outcome is stated in that answer. It describes no prescription and possible in-person or alternative care if treatment is unsuitable. Obtain the applicable payment agreement.

References(7)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Rivo Health (2026). Current public tirzepatide panel, annual-plan qualifier and program disclosures.. Rivo Health.
  4. Rivo Health (2026). Linked treatment terms; current governing text could not be verified during this check.. Rivo Health.
  5. Rivo Health (2026). Current named tirzepatide panel, program and operator disclosures checked October 29, 2026. Rivo Health.
  6. Rivo Health (2026). Linked treatment Terms: normal-TLS access unsuccessful October 29, 2026. Rivo Health.
  7. Rivo Health (2026). Telehealth consent, displaying May 30, 2026; retrieved October 29. Rivo Health.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.